top of page


Training: Ph.D in Clinical Genetics (UCL, London, UK)

Last position: Associate Professor, Stanford University

Cancer Research Focus: Translational

  • Germline genetic and epigenetic risk factors in cancer predisposition (mostly high-risk setting) & inheritance

  • Discovery of, and clinical testing of, DNA methylation biomarkers of cancer for the detection of circulating tumor DNA (ctDNA) for cancer screening (early diagnosis) and monitoring of cancer burden/treatment

Research Projects Underway

Identification and clinical testing of methylated DNA biomarkers for the detection of ctDNA in plasma: Early diagnosis & monitoring for cancer progression/response to treatment

Identification of unusual causes for cancer predisposition in high-risk groups - typically in patients/families who received negative/uninformative/limited CLIA-approved genetic test results (germline mutation, SVs, epimutation, VUS reclassification)

Modes of intergenerational inheritance/erasure of altered constitutional epigenetic states (e.g. MLH1 “epimutation”) – which can be Mendelian and non-Mendelian

  • Amend current universal screening algorithms for colorectal and endometrial cancer to routinely identify cases with “epimutation” as the cause of their mismatch repair deficiency

  • Mechanistic basis: currently using linked-read WGS (Chromium/10X Genomics) to identify cis/trans SNVs, SVs, and retroelement mobilization as potential underlying mechanisms.


Frequently used Wet-lab Techniques

WGBS, SureSelect (deep MethylSeq), Infinium HM arrays, targeted bisulphite sequencing (NGS or clonal), ChIP, promoter reporter

Targeted Pyrosequencing (detection & quantification of hot-spot mutations, CpG methylation, allelic expression, CNV, LOH). Applications: verification, molecular diagnostics, particularly robust for FFPE tissue samples

Sensitive real-time PCR/droplet to detect low-levels of specific mutations, alleles, or methylation (qMSP, MethyLight, MethylHeavy). Applications: Detection of ctDNA in plasma, mosaicism

Megan Hitchins Laboratory: TeamMember


Research Associate III

She joined the lab in January 2018. She received a master's degree in Chemistry from CalState Univeristy, Los Angeles. She has experience with molecular biology both in vitro - in vivo system

bottom of page